Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €3.73 EUR
Change Today +0.024 / 0.65%
Volume 610.8K
EVT On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
Frankfurt
As of 3:35 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by EVOTEC AG (EVT) in the last 6 months

Announced 12/8/14
40.00M for Sanofi, Research Center in Toulouse
Merger/Acquisition

Evotec AG (XTRA:EVT) signed a letter of intent to acquire research center in Toulouse from Sanofi (ENXTPA:SAN) for €40 million on December 8, 2014. Under the terms of the transaction, an initial payment of €40 million will be made, supplemented by gradual payments in stages as the evolution of the program. In 2013, research center in Toulouse generated revenues of €30 million. Out of the total employees, 250 employees of research center in will remain in place for the ...
Read More


EVT's price was unchanged after the transaction was announced on 12/8/14.
Investor / Buyer
Evotec AG
Creditor / Lender
Sanofi
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVT:GR €3.73 EUR +0.024

EVT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Array BioPharma Inc $6.32 USD +0.07
CTI BioPharma Corp $1.79 USD +0.01
Exelixis Inc $2.83 USD +0.26
GlaxoSmithKline SAE £11.15 EGP 0.00
Infinity Pharmaceuticals Inc $13.11 USD +0.44
View Industry Companies
 

Industry Analysis

EVT

Industry Average

Valuation EVT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.1x
Price/Book 2.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOTEC AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.